tiprankstipranks
Trending News
More News >
Elevation Oncology, Inc. (ELEV)
:ELEV
US Market

Elevation Oncology (ELEV) Income Statement

Compare
574 Followers

Elevation Oncology Income Statement

Last quarter (Q4 2024), Elevation Oncology's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Elevation Oncology's net income was $-10.44M. See Elevation Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -39.00K$ -27.00K$ -18.00K$ -15.00K
Operating Expenses
$ 44.70M$ 45.45M$ 94.55M$ 32.05M$ 17.28M
Depreciation and Amortization
$ 0.00$ 39.00K$ 27.00K$ 18.00K$ 15.00K
EBITDA
$ -44.70M$ -41.47M$ -94.52M$ -32.03M$ -17.25M
Operating Income
$ -44.70M$ -45.45M$ -94.55M$ -32.05M$ -17.28M
Other Income/Expenses
$ 261.00K$ -229.00K$ -506.00K$ 7.00K$ 11.00K
Pretax Income
$ -44.44M$ -45.67M$ -95.06M$ -32.04M$ -17.27M
Net Income
$ -44.48M$ -45.70M$ -95.08M$ -32.04M$ -17.27M
Per Share Metrics
Basic EPS
$ -0.78$ -1.34$ -4.09$ -1.38$ -0.73
Diluted EPS
$ -0.78$ -1.34$ -4.09$ -1.38$ -0.73
Weighted Average Shares Outstanding
57.28M 34.08M 23.27M 23.21M 23.76M
Weighted Average Shares Outstanding (Diluted)
57.28M 34.08M 23.27M 23.21M 23.76M
Currency in USD

Elevation Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis